These final results, along with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,two support the thought of focusing on ACKR3 as a novel technique to modulate the opioid process, which could open up new therapeutic avenues for opioid-related disorders. We independently study, https://genghisy951sja7.blogginaway.com/profile